Role of CTLA-4 blockade and dacarbazine therapy following anti-PD-1 resistance in melanoma.

Discov Oncol · 2026 · PMC13103117 · PMID 41838305

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

44 days; p = 0.04 ) and showed a trend toward longer OS (154.5 vs. 89.5 days), with two partial responses in the Ipi10 group (both BRAF V600E).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.